Source: Faith Leonard and Gretchen Jacobson, “What Does the Decline in Medicare Part D Plan Availability Mean for ...
Ascentage Pharma's first approved product, Olverembatinib, is the first novel third-generation BCR-ABL1 inhibitor approved in ...
In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Andrew Willett discussed the path that led him to Lundbeck and ...
The Kerala University of Health Sciences (KUHS) has announced the examination timetable for B.Pharm students under the 2017 ...
Biostar Pharma, Inc., the U.S. wholly-owned subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Stock Code: 2563.HK), today announced that the first patient has ...
THE COMPANY EXPECTS TO RELEASE TOPLINE RESULTS FOR SKNJCT-003 PHASE 2 CLINICAL TRIAL BEFORE THE END OF Q1 2026 AND REQUEST END-OF-PHASE 2 (EOP2) ...
Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA / ACCESS Newswire / ...
Deen Dayal Upadhyaya Gorakhpur University (DDUGU) has announced the DDU Result 2025 for D.Pharm first and second-year ...
A federal judge ruled Thursday that President Trump's months-long deployment of thousands of National Guard forces to the streets of Washington, D.C., violates federal law. U.S. District Judge Jia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results